Detailansicht

Wissensnetz

Person

Anna Sophie Bergmeister-Berghoff (1987-)

Ärztin

Name	Anna Sophie Bergmeister-Berghoff
Zeit	1987- (Lebensdaten)
Ort	Wien (Wirkungsort) Heidelberg (Wirkungsort) Deutschland Österreich
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Prof. Dr. med.
Beruf	Ärztin (charakteristischer Beruf) Onkologin Neurologin Hochschullehrerin
Variante	Anna Berghoff Anna S. Berghoff Anna Sophie Berghoff Anna Sophie Bergmeister- Berghoff
Beziehung	Universitätsklinik für Innere Medizin I (Wien) (Privatdozentin) Klinikum Heidelberg
Quelle	https://www.meduniwien.ac.at/hp/n790-clinical-oncology/research-groupssupervisors/supervisors-a-b/berghoff-anna-sophie/ (Stand: 06.10.2022)
Datensatztyp	Person
GND-Nummer	1139308564
Datensatz-ID	1139308564
Beteiligt an alle anzeigen Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases – data from a tertiary care center Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer Brain metastases from hepatopancreatobiliary malignancies ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors : Invited short review Best of ASCO 2022—central nervous system tumors Emerging systemic treatment options in meningioma Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study ASCO 2021: Highlights in central nervous system tumors SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma LAG-3 expression in the inflammatory microenvironment of glioma Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23 CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases Anti-angiogenic therapies in brain metastases Toward Precision Medicine in Brain Metastases Targeted Therapies for Melanoma Brain Metastases Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Anna Sophie Bergmeister-Berghoff (1987-)

Clinical characteristics, treatment, and outcome of patients with large cell neuroendocrine carcinoma of the lung and brain metastases – data from a tertiary care center

Systemic inflammatory biomarkers as prognostic tools in patients with gastroesophageal adenocarcinoma

Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer

Brain metastases from hepatopancreatobiliary malignancies

ESMO 2022: spotlight on new emerging treatment options in central nervous system tumors : Invited short review

Best of ASCO 2022—central nervous system tumors

Emerging systemic treatment options in meningioma

Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial

SARS-CoV-2-related mortality and treatment delays for cancer patients in Austria : Findings of a multicentric nationwide study

ASCO 2021: Highlights in central nervous system tumors

SARS-CoV-2 screening in cancer outpatients during the second wave of the COVID-19 pandemic : Conclusions for crisis response at a high-volume oncology center

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma

LAG-3 expression in the inflammatory microenvironment of glioma

Development of randomized trials in adults with medulloblastoma - the example of EORTC 1634-BTG/NOA-23

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma

Prognostic assessment in patients with newly diagnosed small cell lung cancer brain metastases: results from a real-life cohort

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling

Chordoid meningiomas can be sub-stratified into prognostically distinct DNA methylation classes and are enriched for heterozygous deletions of chromosomal arm 2p

Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases

Anti-angiogenic therapies in brain metastases

Toward Precision Medicine in Brain Metastases

Targeted Therapies for Melanoma Brain Metastases

Survival prediction using temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases

Tumor-infiltrating lymphocyte subsets and tertiary lymphoid structures in pulmonary metastases from colorectal cancer